Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Prikryl

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Casopis Lekaru Ceskych|January 1, 1980
[The effect of exercise on plasma levels of cyclic adenosine monophosphate in labile essential hypertension]K Rysánek, B Simcíková, B Bílková, et al.
Vnitrni Lekarstvi|November 1, 1989
[Vascular changes in essential hypertension after treatment with enalapril]J Dusek, J Siegelová, P Prikryl, et al.
Activitas Nervosa Superior|December 1, 1987
Long-term physical load and lymphocyte beta 2-adrenergic receptors in essential hypertensionP Prikryl, K Rysánek, V Kunovská, et al.
Casopis Lekaru Ceskych|April 18, 1986
[Interindividual changes in the specific binding of 3H-dihydroalprenolol by beta 2-adrenergic lymphocytic receptors in essential hypertension]P Prikryl, V Kunovská, K Rysánek, et al.
JAMA|December 11, 1991
Prophylactic aspirin treatment: the merits of timing. International Womb-to-Tomb Chronome Study GroupG Cornélissen, F Halberg, P Prikryl, et al.
Vnitrni Lekarstvi|January 1, 1982
[Changes in adrenaline and noradrenaline plasma levels in essential hypertension in relation to emotional and physical stress]P Prikryl, V Kunovská, R Kvetnanský, et al.
Activitas Nervosa Superior|March 1, 1982
Symphathetic activity in labile essential hypertension in young men. Part II. Influence of exercise on plasma catecholaminesK Rysánek, P Prikryl, R Kvetnanský, et al.
Activitas Nervosa Superior|January 1, 1982
Isoprenalin effect on plasma cAMP and blood pressure in labile essential hypertensionP Prikryl, V Kunovská, K Rysánek, et al.
Vnitrni Lekarstvi|February 1, 1985
[Beta-adrenergic receptors in healthy individuals and in patients with essential hypertension]P Prikryl, V Vondrácek, J Prásek, et al.
Vnitrni Lekarstvi|August 1, 1985
[Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation]P Prikryl, K Rysánek, V Vondrácek, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Casopis Lekaru Ceskych|January 1, 1980
[The effect of exercise on plasma levels of cyclic adenosine monophosphate in labile essential hypertension]K Rysánek, B Simcíková, B Bílková, et al.
Vnitrni Lekarstvi|November 1, 1989
[Vascular changes in essential hypertension after treatment with enalapril]J Dusek, J Siegelová, P Prikryl, et al.
Activitas Nervosa Superior|December 1, 1987
Long-term physical load and lymphocyte beta 2-adrenergic receptors in essential hypertensionP Prikryl, K Rysánek, V Kunovská, et al.
Casopis Lekaru Ceskych|April 18, 1986
[Interindividual changes in the specific binding of 3H-dihydroalprenolol by beta 2-adrenergic lymphocytic receptors in essential hypertension]P Prikryl, V Kunovská, K Rysánek, et al.
JAMA|December 11, 1991
Prophylactic aspirin treatment: the merits of timing. International Womb-to-Tomb Chronome Study GroupG Cornélissen, F Halberg, P Prikryl, et al.
Vnitrni Lekarstvi|January 1, 1982
[Changes in adrenaline and noradrenaline plasma levels in essential hypertension in relation to emotional and physical stress]P Prikryl, V Kunovská, R Kvetnanský, et al.
Activitas Nervosa Superior|March 1, 1982
Symphathetic activity in labile essential hypertension in young men. Part II. Influence of exercise on plasma catecholaminesK Rysánek, P Prikryl, R Kvetnanský, et al.
Activitas Nervosa Superior|January 1, 1982
Isoprenalin effect on plasma cAMP and blood pressure in labile essential hypertensionP Prikryl, V Kunovská, K Rysánek, et al.
Vnitrni Lekarstvi|February 1, 1985
[Beta-adrenergic receptors in healthy individuals and in patients with essential hypertension]P Prikryl, V Vondrácek, J Prásek, et al.
Vnitrni Lekarstvi|August 1, 1985
[Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation]P Prikryl, K Rysánek, V Vondrácek, et al.
Pageof 5